CIM analyst estimates
Chimera Investment (CIM) analyst ratings, the average price target and its range, and every firm's latest call.
CIM analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Dec 9, 2025 | RBC Capital | Chimera downgraded to Sector Perform from Outperform at RBC Capital | $13.00 |
| Nov 18, 2025 | UBS | Chimera price target lowered to $15.50 from $16 at UBS | $15.50 |
| Jun 23, 2023 | Credit Suisse | Check Out 3 High-Yielding Dividend Stocks In Financial Sector From Wall Street's Most Accurate Analysts | $5.50 |
| Jul 17, 2022 | Barclays | Chimera price target lowered to $9 from $11 at Barclays | $9.00 |
| Apr 27, 2022 | Barclays | Barclays Maintains Underweight on Chimera Investment, Lowers Price Target to $11 | $11.00 |
- 3 firms rate CIM: 1 buy, 2 hold, 0 sell.
Updated 2026-11-05 12:47 UTC